Andere Sprachen Immuron Limited Nasdaq

Aktien

Verzögert Nasdaq Andere Börsenplätze 18:47:38 21.06.2024			% 5 Tage	% 1. Jan.
2,13 ^USD	-0,93 %		-1,85 %	+13,59 %

05.06.	Immuron Limited ernennt Jeannette Joughin zum Direktor	CI
31.05.	Immuron Limited kündigt Rücktritt von Roger Aston als Non-Executive Director an	CI

Immuron Limited Appoints Jeannette Joughin as Director	05.06.
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05.06.
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05.06.
Immuron Board Changes	31.05.
Immuron CEO Steven Lydeamore to present at Peak Sky High	31.05.
Immuron Limited Announces Resignation of Roger Aston as Non-Executive Director	31.05.
Immuron Limited to Present at the Emerging Growth Conference	07.05.
Immuron Director Resignation	03.05.
Immuron Director Resignation	03.05.
Immuron Limited Announces Stephen Anastasiou Has Resigns as Non-Executive Director	03.05.
Immuron to host Live Virtual Event	15.04.
Immuron Travelan® sales continued strong growth	10.04.
Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	10.04.
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10.04.
Sector Update: Health Care Stocks Gain Late Afternoon	07.03.
Sector Update: Health Care	07.03.
Top Midday Gainers	07.03.
Top Premarket Gainers	07.03.
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07.03.
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	07.03.

Keine Ergebnisse zu dieser Suche